{
  "trial_id": "NCT01034631",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, histological subtype, prior nephrectomy status, number of prior VEGF-directed tyrosine kinase inhibitors, measurable disease status, prior brain metastasis status, prior radiation therapy status, corrected QT interval (QTc), presence of clinically significant infections, liver disease status, histology type, prior treatment with temsirolimus or everolimus, use of anti-coagulation therapy, blood pressure status, history of thrombotic events, peripheral neuropathy grade.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Race (NIH/OMB)",
        "Initial Karnovksy Performance Score (KPS)",
        "Memorial Sloan Kettering Cancer Center Risk Group (MSKCC, Metastatic Site, Number of Prior Therapies"
      ],
      "remaining_candidate_features": [
        "gender",
        "histological subtype",
        "prior nephrectomy status",
        "number of prior VEGF-directed tyrosine kinase inhibitors",
        "measurable disease status",
        "prior brain metastasis status",
        "prior radiation therapy status",
        "corrected QT interval (QTc)",
        "presence of clinically significant infections",
        "liver disease status",
        "histology type",
        "prior treatment with temsirolimus or everolimus",
        "use of anti-coagulation therapy",
        "blood pressure status",
        "history of thrombotic events",
        "peripheral neuropathy grade"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Histological subtype, Prior nephrectomy status, Number of prior VEGF-directed TKI therapies, Measurable disease status, Contraception use, Pregnancy test result, Brain metastasis status, Prior radiation therapy, Corrected QT interval (QTc), Liver disease status, Use of anti-coagulation therapy, Blood pressure, Thrombotic event history, Peripheral neuropathy grade,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Initial Karnovksy Performance Score (KPS)",
        "Memorial Sloan Kettering Cancer Center Risk Group (MSKCC, Metastatic Site, Number of Prior Therapies"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Histological subtype",
        "Prior nephrectomy status",
        "Number of prior VEGF-directed TKI therapies",
        "Measurable disease status",
        "Contraception use",
        "Pregnancy test result",
        "Brain metastasis status",
        "Prior radiation therapy",
        "Corrected QT interval (QTc)",
        "Liver disease status",
        "Use of anti-coagulation therapy",
        "Blood pressure",
        "Thrombotic event history",
        "Peripheral neuropathy grade"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Eastern Cooperative Oncology Group (ECOG) Performance Status, Histological proof of clear cell RCC, Number of prior VEGF-directed tyrosine kinase inhibitors, Measurable disease according to RECIST, Corrected QT interval (QTc), Systolic Blood Pressure, Diastolic Blood Pressure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Number of Prior Therapies",
          "Number of prior VEGF-directed tyrosine kinase inhibitors"
        ]
      ],
      "remaining_reference_features": [
        "Initial Karnovksy Performance Score (KPS)",
        "Memorial Sloan Kettering Cancer Center Risk Group (MSKCC, Metastatic Site"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Eastern Cooperative Oncology Group (ECOG) Performance Status",
        "Histological proof of clear cell RCC",
        "Measurable disease according to RECIST",
        "Corrected QT interval (QTc)",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, histological proof of clear cell RCC, prior nephrectomy status, number of prior VEGF-directed tyrosine kinase inhibitors, measurable disease according to RECIST, Eastern Cooperative Oncology Group (ECOG) performance status, corrected QT interval (QTc), blood pressure, presence of brain metastases, presence of other active malignancies, prior cancer treatment, prior radiation therapy, liver function tests, creatinine clearance, hemoglobin, platelet count, white blood cell count.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Number of Prior Therapies",
          "number of prior VEGF-directed tyrosine kinase inhibitors"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Initial Karnovksy Performance Score (KPS)",
        "Memorial Sloan Kettering Cancer Center Risk Group (MSKCC, Metastatic Site"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "histological proof of clear cell RCC",
        "prior nephrectomy status",
        "measurable disease according to RECIST",
        "Eastern Cooperative Oncology Group (ECOG) performance status",
        "corrected QT interval (QTc)",
        "blood pressure",
        "presence of brain metastases",
        "presence of other active malignancies",
        "prior cancer treatment",
        "prior radiation therapy",
        "liver function tests",
        "creatinine clearance",
        "hemoglobin",
        "platelet count",
        "white blood cell count"
      ]
    }
  }
}